CAG
TCBP

Csenge Advisory Group’s TC BioPharm (Holdings) plc American Depositary Shares TCBP Stock Holding History

Csenge Advisory Group’s Portfolio TCBP Stock Details TCBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-75
Closed -$9.89K – 767
2024
Q2 		$9.89K Sell
75
-16
-18% -$3.2K ﹤0.01% 660
2024
Q1 		$19K Buy
+91
New +$22.8K ﹤0.01% 703
2023
Q4 		– Sell
-8
Closed -$11.2K – 716
2023
Q3 		$11.2K Buy
+8
New +$13.2K ﹤0.01% 634

Other funds holding TCBP

FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $6.53B AUM 20.48% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
NECFA
New England Capital Financial Advisors Meriden, Connecticut $365M AUM 17.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
SWM
Sanctuary Wealth Management Pocatello, Idaho $151M AUM 17.94% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Csenge Advisory Group's TCBP Position: Q3 2024 in Review

Csenge Advisory Group sold out of TC BioPharm (Holdings) plc American Depositary Shares (TCBP) in Q3 2024, closing a stake of 75 shares — an estimated $9.89K sold.

Csenge Advisory Group first reported a position in TCBP in Q3 2023 and held it in 3 quarters. The position peaked at $19K in Q1 2024. 7 funds tracked by Wall St. Rank hold TCBP as of Q3 2024.

  • Csenge Advisory Group reported no remaining TC BioPharm (Holdings) plc American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Csenge Advisory Group sold 75 TC BioPharm (Holdings) plc American Depositary Shares shares in Q3 2024, an estimated $9.89K.
  • Csenge Advisory Group first reported a position in TC BioPharm (Holdings) plc American Depositary Shares in Q3 2023 and held it in 3 quarters.
  • Csenge Advisory Group's TC BioPharm (Holdings) plc American Depositary Shares position peaked at $19K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held TC BioPharm (Holdings) plc American Depositary Shares as of Q3 2024.

Based on Csenge Advisory Group's 13F filing for Q3 2024, filed 13 Nov 2024.